This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations of Feng Wan in Biotin-Containing Compounds
Introduction
Feng Wan is an accomplished inventor based in Seattle, WA (US). He has made significant contributions to the field of biochemistry, particularly in the development of water-soluble multi-biotin-containing compounds. His innovative work has implications for various applications, including targeted therapies and diagnostics.
Latest Patents
Feng Wan holds a patent for "Water soluble multi-biotin-containing compounds." This patent describes water-soluble discrete multi-biotin-containing compounds that feature at least three biotin moieties. These compounds may also include moieties that provide resistance to cleavage by biotinidase or that can be cleaved in vitro or in vivo. Additionally, the compounds may contain a reactive moiety that allows for reactions with other functional moieties, such as targeting or therapeutic agents. The patent also discloses biotinylation reagents with water-soluble linker moieties and methods for amplifying binding sites for biotin-binding proteins.
Career Highlights
Feng Wan is affiliated with the University of Washington, where he continues to advance research in biochemistry. His work has garnered attention for its potential to enhance the effectiveness of biotin-binding proteins in various applications.
Collaborations
Feng Wan has collaborated with notable colleagues, including D Scott Wilbur and Pradip M Pathare. Their combined expertise contributes to the innovative research being conducted at the University of Washington.
Conclusion
Feng Wan's contributions to the field of biochemistry, particularly through his patent on water-soluble multi-biotin-containing compounds, highlight his role as a significant inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
